In other news, another study has raised concerns about the safety of what people consume on a daily basis. Amid all the things that we know of, which consists heavy metals, your regular used toothpaste is also now on the list. As per the consumer advocacy group Lead Safe Mama, a large number of popular toothpaste products contain heavy metals. These are lead, arsenic, mercury, and cadmium. The study also found that those marketed as safe for children too contain these metals.

How Was The Research Conducted?

The organization tested 51 different toothpaste brands. The results then revealed that 90% of these samples were contaminated with lead. Of them, 65% contained arsenic, and nearly half had mercury, while one-third tested positive for cadmium. The Guardian was the first one to report these findings.

What Inspired This Research?

Tamara Rubin, who is the founder of Lead Safe Mama, has been investigating heavy metal contamination for over a decade now. Her interest began when she saw families whose children had alarmingly high levels of metals in their blood. Her past observations have also already highlighted the content of Earthpaste, which had raised concerns.

She said that these recent findings were "unconscionable - especially in 2025". She also criticised the companies which were involved for failing to take responsibility or initiate corrective measures. “None of the companies dragged after the outcome admitted to working towards eliminating lead from their toothpastes,” she said. Instead, some brands reportedly issued cease-and-desist letters in response to Rubin’s findings, which she publicly addressed on her blog, tamararubin.com.

Which Popular Brands Are On The Red Flag List?

The report noted for some of the top-selling toothpaste brands in the US, including the ones which are marketed as safe for children. The brand names are:

• Crest
• Sensodyne
• Colgate
• Tom’s of Maine
• Dr Bronner’s
• Davids
• Dr Jen
• Dr Brite

What Ingredients Do These Toothpastes Contain?

Rubin’s research suggests that certain ingredients are consistently linked to higher levels of heavy metal contamination. Specifically, hydroxyapatite, calcium carbonate, and bentonite clay were found to be contributing factors.

Bentonite clay, often included for its cleaning properties, showed the highest levels of contamination. Hydroxyapatite, known for aiding calcium absorption, and calcium carbonate, commonly used for stain removal, were also found to contain troubling amounts of lead and other metals. Toothpastes that did not include these ingredients—such as Dr Brown’s Baby Toothpaste—were free of contamination, according to the findings.

What Has Been The Brands' Response?

The companies who have been red listed have responded, however, all in different ways. While some offered explanations, others have downplayed the findings. Dr Jen's for instance shared a graph with Lead Safe Mama which showed their toothpaste's metal concentration was well below the US Food and Drug Administration's safety thresholds.

However, Rubin challenged this defence, arguing that the FDA’s limits are outdated and not aligned with the current scientific consensus. “All federal agencies agree that there is no safe level of lead exposure for human beings, especially children,” she stated. In a pointed rebuttal, Rubin added, “I expected more from you. I assumed your product would not have harmful toxicants that could impact my children.”

She also criticised Dr Jen’s for using safety standards intended for fluoride toothpaste, noting that the tested product was non-fluoride, for which safety limits are even stricter—and still too high in her view.

What Do Experts Say?

The US Centers for Disease Control and Prevention (CDC) maintains that no level of lead exposure is considered safe. However, the loophole is that while the reports may have found lead levels which do not exceed the federal limits, but they do surpass state limits in Washington and California, and many more like them.

California’s legal lead limit in baby food is six parts per billion (ppb), and the Baby Food Safety Act of 2024 aims to cap children’s food lead levels at 10 ppb. However, the toothpaste samples flagged by Lead Safe Mama frequently exceeded these numbers, raising broader questions about regulatory oversight and consumer safety.

A federal panel of vaccine advisers met Friday, September 19, 2025, to discuss changes to COVID-19 vaccine access, in a session marked by technical glitches, procedural confusion, and heated debates among experts.

The Advisory Committee on Immunization Practices (ACIP) ultimately withdrew its most controversial proposal, which would have required a prescription for the vaccine. While this avoids the strictest restriction, it could still make COVID-19 vaccines less accessible than in previous years. Keep reading for detailed updates and what this could mean for you.

CDC Updates COVID-19 Vaccine Guidance: What You Need to Know

The US Centers for Disease Control and Prevention (CDC) vaccine advisers have voted to move away from a broad recommendation for COVID-19 vaccines. Under the new guidance, individuals are encouraged to make vaccination decisions through “shared clinical decision-making” with a healthcare provider.

ALSO READ: American Heart Association Updates Hypertension Guidelines: Here’s What To Know

The Advisory Committee on Immunization Practices (ACIP) was divided on whether a prescription should be required for the vaccine, with a 6-6 tie broken by committee chair Dr. Martin Kulldorff, who voted against the requirement.

According to the panel, people aged 65 and older should decide on vaccination in consultation with a doctor or healthcare provider. The same approach is recommended for those aged 6 months to 64 years, emphasising that the benefits are greatest for individuals at higher risk of severe COVID-19 and lowest for those at lower risk, based on CDC-defined risk factors.

These recommendations are not final and will be reviewed by Acting CDC Director Jim O’Neill for approval. Changes could still be made before official implementation.

Who Should Consult a Healthcare Provider Before Vaccination?

On September 19, 2025, the CDC’s Advisory Committee on Immunization Practices (ACIP) voted to discontinue its universal recommendation for COVID-19 vaccinations. Instead, the committee endorsed a "shared clinical decision-making" approach, advising individuals to consult with healthcare providers before receiving the vaccine. This decision particularly affects individuals under 65 without underlying health conditions, as they are now encouraged to make vaccination decisions in collaboration with their clinicians. This new action is important for:

High-Risk Groups

The new guidance underscores the importance of shared decision-making for individuals aged 65 and older, as well as those under 65 with underlying health conditions. For these groups, the ACIP recommends discussing the risks and benefits of vaccination with a healthcare provider. This approach aims to ensure that vaccination decisions are tailored to individual health profiles and circumstances, as per The Washington Post.

Access and Implementation

Despite the shift in recommendations, COVID-19 vaccines will remain accessible to all individuals. Major insurers have committed to continuing coverage through at least 2026. However, the change may impact access, especially for those without regular access to healthcare providers. Pharmacists, who previously administered vaccines without prescriptions, will now be limited to providing them only to individuals who have consulted with a healthcare provider.

Access and Coverage Amid the CDC Changes

A spokesperson for the U.S. Department of Health and Human Services emphasized that the move to shared clinical decision-making will not limit vaccine access. Immunization coverage will continue through all payment mechanisms, including entitlement programs like Children’s Health Insurance Program (CHIP), Medicaid, and Medicare, as well as insurance plans available via the federal Health Insurance Marketplace.

ALSO READ: CDC Advisers Postpone Vote On Newborn Hepatitis B Shot; What It Means For Your Child

This ensures that even with the shift from a universal recommendation, individuals consulting their healthcare providers can still receive COVID-19 vaccines without facing coverage barriers.

Hepatitis B Vaccine Vote Postponed

The CDC advisory committee’s COVID-19 discussions followed a turbulent start to their meeting, including a redo of earlier guidance on the MMRV (measles, mumps, rubella, and chickenpox) vaccines. A notable development was the postponement of a vote on the hepatitis B vaccine for newborns.

Advisers voted 11–1 to delay changes to the current recommendation, which involves giving babies a hepatitis B shot at birth before hospital discharge. The discussion had explored the possibility of waiting until newborns are at least a month old to receive the vaccine. a recommendation that would have marked a significant change in neonatal care protocols, as per ABC News.

Most of us have felt our heartbeat quicken during a tense meeting or after one too many cups of coffee. Usually, we brush it aside. But for millions of people, that racing pulse signals something much more serious, high blood pressure. Often called the ‘silent killer,’ it shows few warning signs until it leads to major complications.

According to the 2025 American Heart Association Statistical Update, nearly half of U.S. adults, around 122 million people, are living with high blood pressure, a top preventable cause of heart disease, stroke, and early death. Shockingly, only about one in four have their condition under control.

With cases climbing each year, the American Heart Association has introduced new guidelines on blood pressure management. Here’s a closer look at the changes and what they could mean for you.

The New AHA-ACC Hypertension Guidelines: What You Should Know

In August 2025, the American Heart Association (AHA) and the American College of Cardiology (ACC) updated their blood pressure guidelines, with an emphasis on earlier intervention and personalized care. High blood pressure remains one of the most common and dangerous health conditions, but these updated recommendations aim to catch risks sooner and improve outcomes.

Key Updates at a Glance

• Earlier Treatment: People with a 10-year cardiovascular disease risk of 10% or more are advised to begin medication sooner, along with lifestyle changes.
• Personalized Risk Assessment: Doctors are encouraged to use the PREVENT™ calculator to estimate a person’s 10-year risk of heart attack, stroke, or heart failure.
• Expanded Lab Testing: New tests, such as the urine albumin: creatinine ratio, are now recommended to help tailor treatment.
• Lifestyle First: The guidelines reinforce limiting sodium intake to 1,500 mg per day, managing weight, and staying physically active.
• Alcohol Limits: Men should limit to two drinks a day, women to one.

Blood Pressure Categories (Unchanged Since 2017)

• Normal: <120 / <80 mm Hg
• Elevated: 120–129 / <80 mm Hg
• Stage 1 Hypertension: 130–139 / 80–89 mm Hg
• Stage 2 Hypertension: ≥140 / ≥90 mm Hg

When to Start Treatment

ALSO READ: Eating A Banana At 11 Am Could Protect Your Heart And Lower Cholesterol: British Heart Foundation Reveals How

For Stage 2 hypertension (≥140/90), doctors may recommend combination pills, including ACE inhibitors, ARBs, calcium-channel blockers, or thiazide diuretics.

What Is High Blood Pressure?

Many people live with high blood pressure without even knowing it. The condition develops when blood flows through your arteries with greater force than normal, putting extra strain on the heart and blood vessels.

Blood pressure is measured using two numbers, written like this: 120/80 mm Hg and read as “120 over 80.” The first number, called systolic pressure, shows the force of blood when the heart pumps it out. The second, known as diastolic pressure, measures the pressure when the heart relaxes and refills between beats.

ALSO READ: High Blood Pressure Affects Nearly Half Of US Adults: 2025 American Heart Association Report Reveals, Who Is At More Risk

Understanding what your blood pressure numbers mean is the first step toward protecting your heart and overall health. Since high blood pressure often shows no obvious symptoms, regular monitoring and adopting healthy habits like balanced eating, exercise, and stress management can make a big difference. Small, consistent changes today can help lower risks of serious complications like heart disease and stroke in the future.

A federal advisory committee postponed Friday’s planned vote on whether to delay some newborns’ first hepatitis B vaccine, disrupting the second day of a closely watched meeting on updates to the childhood immunization schedule.

The Centers for Disease Control and Prevention (CDC) panel, recently reshaped by Health and Human Services Secretary Robert F. Kennedy Jr., raised questions about the safety and necessity of the hepatitis B vaccine during Thursday’s discussions. With the vote now postponed, parents may be wondering what this means for their child’s vaccination schedule. Below, we make it easy for you.

CDC Advisers Postpone Vote On Newborn Hepatitis B ShotHealth experts welcomed the news as the vaccine panel under Health and Human Services Secretary Robert F. Kennedy Jr. voted to maintain current guidance on a vaccine that has protected children for decades.

For nearly 35 years, the Centers for Disease Control and Prevention (CDC) has recommended that newborns receive their first dose of the hepatitis B vaccine within 24 hours of birth.

On September 19, the Advisory Committee on Immunization Practices (ACIP) postponed a vote that would have delayed the first dose until at least one month after birth for babies born to mothers who test negative for hepatitis B. This comes after the panel’s September 18 meeting, where members voted to no longer recommend the combined MMRV vaccine for children under 4 years old.

ALSO READ: As CDC Advisers Vote Against MMRV Vaccine For Kids Under 4, Here's What Parents Should Know

Initially, the panel had voted to continue covering these vaccines for children under 4 through the Vaccines for Children programme, which ensures access for families who may not afford them. However, they later voted to remove that coverage. While most adults recover fully from hepatitis B, about 90% of infected infants and 30% of children infected between ages 1 and 5 develop lifelong infections, which can lead to severe liver damage, liver cancer, or even death, according to the CDC.

What This Decision Means for Your Child’s Health

For now, newborns will continue to receive the hepatitis B vaccine within 24 hours of birth, keeping the long-standing protection policy in place. Experts say this early dose is crucial because infants are far more likely than older children or adults to develop chronic hepatitis B if infected.

The panel had been considering a delay for babies born to mothers who test negative for hepatitis B, but keeping the current schedule ensures that children remain safeguarded against a serious liver infection from day one.

Safety and Effectiveness of the Hepatitis B Birth Dose

The hepatitis B vaccine given within 24 hours of birth is considered both safe and highly effective. Decades of research and real-world use have shown that newborns tolerate the vaccine well, with only minor side effects such as mild soreness at the injection site or a low-grade fever in rare cases.

Giving the first dose at birth is particularly important because infants are far more vulnerable to developing chronic hepatitis B if infected. Around 90% of infants who contract the virus go on to develop lifelong infections, which can lead to severe liver problems, liver cancer, or even premature death.

ALSO READ: WHO Guidelines On Weight Loss Drugs For Obesity

Early vaccination helps the immune system recognise and fight the virus, providing protection from the very first hours of life. The birth dose, followed by subsequent doses as part of the recommended schedule, has been credited with dramatically reducing hepatitis B infections in young children and protecting millions of babies worldwide.